Dr. Angela Fitch, current Past President of the Obesity Medicine Association

FDA-approved GLP-1 medications are revolutionary in transforming the treatment of obesity. These innovative medications have supported patients in managing the symptoms of several chronic conditions, including obesity, diabetes, sleep apnea, heart failure and chronic kidney disease—and ongoing studies suggest they have the potential to treat many other conditions, including substance use disorders. With Chris Edwards to talk more about this is Dr. Angela Fitch, current Past President of the Obesity Medicine Association